Amneal Pharmaceuticals, Inc. (AMRX) stock analysis
In our weekly check, Amneal Pharmaceuticals, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 5.
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NYSE as AMRX.
What our checks show for AMRX
Red flags
- Net debt is 4.7x a year of EBITDA (debt/equity 6.18). That limits room in a downturn and raises refinancing risk.
- The net margin is only 4.6%: little room if costs rise.
- The stock has fallen as much as 98% from a peak. Would you have held through that?
- The share count grew by 79.1% in 2 years: each shareholder owns a smaller slice.
- Pay in shares equals 72% of free cash flow: it dilutes shareholders.
Warning signs
- Operating profit covers interest only 2.2 times: a weak year could make the payments hard.
- Earnings per share fell 20.6% a year over the last 3 years.
- Free cash flow is only 1.3% of revenue.
- The stock is still below its previous peak.
- Beta 1.25: the stock usually moves more than the market, both up and down.
Strengths
- The net margin rose by 4.1 points over 5 years, to 4.6%.
- The gross margin is 40.2% and has risen by 3.5 points: pricing power is holding.
- Operating cash flow is 1.24x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 72.7% a year over the next years.
- Analysts expect the net margin to improve by 9 points from today's 4.6%.
- Actively traded: about 3.1 million shares a day.
Similar companies
ALKS · LNTH · ELAN · BHC · HCM · VTRS
Questions
What grade does Amneal Pharmaceuticals, Inc. (AMRX) have?
In our weekly check, Amneal Pharmaceuticals, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 5. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of AMRX stock?
This week's biggest flags for Amneal Pharmaceuticals, Inc.: High debt, Thin margins, Deep past fall. In total 10 of 23 checks show a warning or a red flag.
What does Amneal Pharmaceuticals, Inc. do?
Amneal Pharmaceuticals, Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NYSE as AMRX.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis